These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6803537)

  • 1. Indomethacin is a competitive inhibitor of the binding of the chemotactic peptide formyl-Met-Leu-Phe to human polymorphonuclear leukocytes.
    Abita JP
    Agents Actions; 1981 Dec; 11(6-7):610-2. PubMed ID: 6803537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of indomethacin on the binding of the chemotactic peptide formyl-Met-Leu-Phe on human polymorphonuclear leukocytes.
    Cost H; Gespach C; Abita JP
    FEBS Lett; 1981 Sep; 132(1):85-8. PubMed ID: 6271584
    [No Abstract]   [Full Text] [Related]  

  • 3. Deactivation of human neutrophil chemotaxis by chemoattractants: effect on receptors for the chemotactic factor f-Met-Leu-Phe.
    Donabedian H; Gallin JI
    J Immunol; 1981 Sep; 127(3):839-44. PubMed ID: 6790618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human neutrophils contain an intracellular pool of putative receptors for the chemoattractant N-formyl-methionyl-leucyl-phenylalanine.
    Fletcher MP; Gallin JI
    Blood; 1983 Oct; 62(4):792-9. PubMed ID: 6309284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fate of the N-formyl-chemotactic peptide receptor in stimulated human granulocytes: subcellular fractionation studies.
    Jesaitis AJ; Naemura JR; Painter RG; Schmitt M; Sklar LA; Cochrane CG
    J Cell Biochem; 1982; 20(2):177-91. PubMed ID: 6302115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-idiotype as antibody against the formyl peptide chemotaxis receptor of the neutrophil.
    Marasco WA; Becker EL
    J Immunol; 1982 Feb; 128(2):963-8. PubMed ID: 7054297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoattractant receptor functions in human polymorphonuclear leukocytes are divergently altered by membrane fluidizers.
    Yuli I; Tomonaga A; Synderman R
    Proc Natl Acad Sci U S A; 1982 Oct; 79(19):5906-10. PubMed ID: 6310554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-f Met-Leu-Phe: similarities in fine specificity with the formyl peptide chemotaxis receptor of the neutrophil.
    Marasco WA; Showell HJ; Freer RJ; Becker EL
    J Immunol; 1982 Feb; 128(2):956-62. PubMed ID: 7033385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphotericin B alters the affinity and functional activity of the oligopeptide chemotactic factor receptor on human polymorphonuclear leukocytes.
    Lohr KM; Snyderman R
    J Immunol; 1982 Oct; 129(4):1594-9. PubMed ID: 6286769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition by nonsteroidal antiinflammatory drugs of luminol-dependent human-granulocyte chemiluminescence and [3H]FMLP binding. Effect of sulindac sulfide, indomethacin metabolite, and optical enantiomers (+) and (-) MK830.
    Van Dyke K; Peden D; Van Dyke C; Jones G; Castranova V; Ma J
    Inflammation; 1982 Mar; 6(1):113-25. PubMed ID: 7085041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of granulocyte response to the chemoattractant F-Met-Leu-Phe.
    Dahlgren C; Stendahl O
    Adv Exp Med Biol; 1982; 155():107-12. PubMed ID: 6297266
    [No Abstract]   [Full Text] [Related]  

  • 12. The formylpeptide chemotactic receptor on rabbit peritoneal neutrophils. I. Evidence for two binding sites with different affinities.
    Mackin WM; Huang CK; Becker EL
    J Immunol; 1982 Oct; 129(4):1608-11. PubMed ID: 6286772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of human neutrophil receptors for the chemoattractant fmet-leu-phe.
    Gallin JI; Seligmann BE; Fletcher MP
    Agents Actions Suppl; 1983; 12():290-308. PubMed ID: 6301232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of human neutrophil secretion, chemoattractant receptor mobilization, and enhanced functional capacity.
    Fletcher MP; Seligmann BE; Gallin JI
    J Immunol; 1982 Feb; 128(2):941-8. PubMed ID: 6274963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of polymorphonuclear leukocyte chemiluminescent response to the chemoattractant f-Met-Leu-Phe.
    Dahlgren C; Magnusson KE; Stendahl O; Sundqvist T
    Int Arch Allergy Appl Immunol; 1982; 68(1):79-83. PubMed ID: 6281196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of chemotactic factor-induced neutrophil responsiveness by arachidonic acid.
    Naccache PH; Molski TF; Volpi M; Mackin WM; Becker EL; Sha'afi RI
    J Cell Physiol; 1983 Jun; 115(3):243-8. PubMed ID: 6406520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of an ECF-A and formyl methionyl chemotactic peptides on oxidative metabolism of human eosinophils and neutrophils.
    Beswick PH; Kay AB
    Clin Exp Immunol; 1981 Feb; 43(2):399-407. PubMed ID: 6268337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ionic basis of chemotaxis. Separate cation requirements for neutrophil orientation and locomotion in a gradient of chemotactic peptide.
    Marasco WA; Becker EL; Oliver JM
    Am J Pathol; 1980 Mar; 98(3):749-68. PubMed ID: 6767408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5,8,11,14-Eicosatetraynoic acid (ETYA) inhibits binding of N-formyl-methionyl-leucyl-phenylalanine (FLMP) to its receptor on human granulocytes. A note of caution.
    Atkinson JP; Simchowitz L; Mehta J; Stenson WF
    Immunopharmacology; 1982 Feb; 4(1):1-9. PubMed ID: 6277829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the rabbit polymorphonuclear leukocyte membrane "Na+, K+"-ATPase by chemotactic factor.
    Becker EL; Talley V; Showell HJ; Naccache PH; Sha'afi RI
    J Cell Biol; 1978 May; 77(2):329-33. PubMed ID: 148465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.